Literature DB >> 15339394

Induction of mucin secretion from human bronchial tissue and epithelial cells by rhinovirus and lipopolysaccharide.

Shao-Heng He1, Jian Zheng, Ming-Ke Duan.   

Abstract

AIM: To examine the effects of rhinovirus and lipopolysaccharide (LPS) on mucin secretion from bronchial tissue and epithelial cells in vitro.
METHODS: Human small bronchial tissue fragments (HSBTF) and human bronchial epithelial cells (HBEC) were cultured with rhinovirus 16 and LPS, respectively and culture supernatants were collected for mucin measurement. To determine mucin levels in the culture supernatants, a MUC5AC enzyme linked immunosorbent assay and an enzyme linked lectin assay procedure with dolichos biflorus agglutinin (DBA) were developed, and mucin release was expressed as percentage increased (or decreased) secretion over baseline level.
RESULTS: A concentration-dependent release of DBA mucin and MUC5AC mucin were observed when HSBTF were infected with various concentrations of rhinovirus 16 at 37 degree. The maximum-induced DBA mucin and MUC5AC mucin release were approximately 258 % and 83 % over baseline. The response of HSBTF to rhinovirus was completely abolished by metabolic inhibitors. Rhinovirus was also able to induce a concentration-dependent release of DBA mucin and MUC5AC mucin from primarily cultured HBEC. LPS 100 mg/L was able to provoke up to approximately 19 % and 54 % increase in DBA and MUC5AC mucin release over baseline, respectively from HSBTF, and 3.1 % and 57 % increase from HBEC at 20 h. Soybean trypsin inhibitor (SBTI) 30 mg/L was able to inhibit LPS-induced mucin release from HSBTF and HBEC.
CONCLUSION: Rhinovirus is able to induce mucin secretion from human bronchial tissue and bronchial epithelial cells in vitro. LPS can induce MUC5AC mucin release from HSBTF and HBEC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339394

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  9 in total

Review 1.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors:  Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Murine cytomegalovirus influences Foxj1 expression, ciliogenesis, and mucus plugging in mice with allergic airway disease.

Authors:  Carol A Wu; John J Peluso; John D Shanley; Lynn Puddington; Roger S Thrall
Journal:  Am J Pathol       Date:  2008-02-07       Impact factor: 4.307

Review 4.  Mucin gene expression in rhinitis syndromes.

Authors:  Asunción Martínez-Antón; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2006-05       Impact factor: 4.919

Review 5.  New treatment regimes for virus-induced exacerbations of asthma.

Authors:  Michael R Edwards; Tatiana Kebadze; Malcolm W Johnson; Sebastian L Johnston
Journal:  Pulm Pharmacol Ther       Date:  2005-11-10       Impact factor: 3.410

Review 6.  The role of viruses in acute exacerbations of asthma.

Authors:  David J Jackson; Sebastian L Johnston
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

7.  Rhinovirus C replication is associated with the endoplasmic reticulum and triggers cytopathic effects in an in vitro model of human airway epithelium.

Authors:  Talita B Gagliardi; Monty E Goldstein; Daniel Song; Kelsey M Gray; Jae W Jung; Maxinne A Ignacio; Kimberly M Stroka; Gregg A Duncan; Margaret A Scull
Journal:  PLoS Pathog       Date:  2022-01-07       Impact factor: 6.823

Review 8.  Influence of the Microbiome on Chronic Rhinosinusitis With and Without Polyps: An Evolving Discussion.

Authors:  Kyle S Huntley; Joshua Raber; Lauren Fine; Jonathan A Bernstein
Journal:  Front Allergy       Date:  2021-10-01

Review 9.  Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.

Authors:  Michael R Edwards; Nathan W Bartlett; Deborah Clarke; Mark Birrell; Maria Belvisi; Sebastian L Johnston
Journal:  Pharmacol Ther       Date:  2008-10-06       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.